Colostral antibody protection and interference with immunity in lambs born from sheep vaccinated with an inactivated Bluetongue serotype 8 vaccine

Vaccine

Volumn 28, Issue 15, 2010, Pages 2749-2753

  Oura, C A L ^a   Wood, J L N ^b   Floyd, T ^b   Sanders, A J ^a   Bin Tarif, A ^a   Henstock, M ^a   Edwards, L ^a   Simmons, H ^c   Batten, C A ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

Bluetongue; Colostral antibodies; Inactivated vaccines; Interference

Indexed keywords

BLUETONGUE ORBIVIRUS VACCINE; BOVILIS; COLOSTRUM ANTIBODY; INACTIVATED VIRUS VACCINE; MATERNAL ANTIBODY; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; BLUETONGUE ORBIVIRUS; BLUETONGUE ORBIVIRUS SEROTYPE 8; BODY TEMPERATURE; COLOSTRUM; CONTROLLED STUDY; FEMALE; HUMORAL IMMUNITY; LAMB; NEWBORN; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; RNA VIRUS INFECTION; SHEEP; VACCINATION; VACCINATION REACTION; VIRUS ISOLATION;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BLUETONGUE; BLUETONGUE VIRUS; COLOSTRUM; EUROPE; FEMALE; IMMUNIZATION, SECONDARY; SHEEP; SURVIVAL ANALYSIS; VACCINATION; VIRAL VACCINES;

EID: 77949265943     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.01.028     Document Type: Article

References (10)

1. Saegerman C., Berkvens D., and Mellor P.S. Bluetongue epidemiology in the European Union. Emerging Infectious Diseases 14 4 (2008) 539-544
2. Hoffmann B., Sasserath M., Thalheim S., Bunzenthal C., Strebelow G., and Beer M. Bluetongue virus serotype 8 reemergence in Germany, 2007 and 2008. Emerging Infectious Diseases 14 9 (2008) 1421-1423
3. Shaw A., Monaghan P., Alpar H.O., Anthony S., Darpel K.E., Batten C.A., et al. Development and validation of a real-time RT-PCR assay to detect genome bluetongue virus segment 1. Journal of Virological Methods 145 2 (2007) 115-126
4. Haig DGMaRAA D.A. The cytopathic action of Bluetongue virus on tissue cultures and its application to the detection of antibodies in the serum of sheep. Onderstepoort Journal of Veterinary Research 27 2 (1956)
5. OIE. Manual of diagnostic tests and vaccines for terrestrial animals, sixth ed. Paris; 2008.
6. Eschbaumer M., Hoffmann B., König P., Teifke J.P., Gethmann J.M., Conraths F.J., et al. Efficacy of three inactivated vaccines against Bluetongue virus serotype 8 in sheep. Vaccine 27 31 (2009) 4169-4175
7. Oura C., Wood J., Sanders A., Bin-Tarif A., Henstock M., Edwards L., et al. Seroconversion, neutralising antibodies and protection in bluetongue serotype 8 vaccinated sheep. Vaccine 27 (2009) 7326-7330
8. Savini G., MacLachlan N.J., Sanchez-Vizcaino J.-M., and Zientara S. Vaccines against Bluetongue in Europe. Comparative immunology. Microbiology and Infectious Diseases 31 2-3 (2008) 101-120
9. Savini G., Monaco F., Citarella R., Calzetta G., Panichi G., Ruiu A., et al. Monovalent modified-live vaccine against Bluetongue virus serotype 2: immunity studies in cows. Veterinaria Italiana 40 4 (2004) 664-667
10. Savini G., Hamers C., Conte A., Migliaccio P., Bonfini B., Teodori L., et al. Assessment of efficacy of a bivalent BTV-2 and BTV-4 inactivated vaccine by vaccination and challenge in cattle. Veterinary Microbiology 133 1-2 (2009) 1-8